content_top
43 companies, 1 interpreter! Insight, foresight
and recommendation 

Pluristem Therapeutics, Inc. (PSTI)

1.28
0.11
(9.40%)
Sep 11, 4:00PM EDT
content_middle

Pluristem Therapeutics Inc., a bio-therapeutics company, engages in the research, development, and commercialization of standardized cell therapy products and related technologies for the treatment of life threatening diseases. The company’s products are derived from human placenta that is a non-controversial, non-embryonic, and adult cell source. Its Placental adherent stromal cells are grown in the company's proprietary PluriX three-dimensional process that allows cells to grow in a natural environment. The company develops placenta expanded cells (PLX) and peripheral artery disease cells, an allogeneic therapeutic product that is in Phase-II clinical trials for the treatment of intermittent claudication, critical limb ischemia, and Buerger's disease. Its PLX product is developed for the treatment of muscle injury, bone marrow diseases, inflammatory bowel disease, and multiple sclerosis, as well as for pulmonary disorders, acute radiation syndrome, acute myocardial infarction, diabetic diastolic heart failure, neuropathic pain, inflammatory bowel disease, multiple sclerosis, and ischemic stroke for which the product is in various pre-clinical trials. Pluristem Therapeutics Inc. is also involved in the development and commercialization of a PLX cell-based product for the treatment of pulmonary arterial hypertension through its license agreement with the United Therapeutics Corporation. The company was formerly known as Pluristem Life Systems Inc. and changed its name to Pluristem Therapeutics Inc. in November 2007. Pluristem Therapeutics Inc. was founded in 2001 and is headquartered in Haifa, Israel.

Previous Close: 
1.17
Open: 
1.19
Bid: 
1.16
Ask: 
1.31
1yr Target Price: 
2.75
Day's Range: 
1.16 - 1.37
52wk Range: 
1.04 - 1.75
Volume: 
835778
Average Daily Volume: 
199730
Market Capitalization: 
123.30M
Trailing Annual Dividend Yield: 
N/A
Shares Outstanding: 
96331000M
content_right

Pages